Terms: = Breast cancer AND TSC1, KIAA0243, 7248, ENSG00000165699, TSC, MGC86987, LAM, hamartin AND Prognosis
9 results:
1. Zinc finger and SCAN domain-containing protein 18 is a potential DNA methylation-modified tumor suppressor and biomarker in breast cancer.
Wang Y; Luo Y; Fu S; He L; Pan G; Fan D; Wen Q; Fan Y
Front Endocrinol (Lausanne); 2023; 14():1095604. PubMed ID: 37223020
[TBL] [Abstract] [Full Text] [Related]
2. Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
Dono A; Takayasu T; Yan Y; Bundrant BE; Arevalo O; Lopez-Garcia CA; Esquenazi Y; Ballester LY
Neurosurgery; 2021 Feb; 88(3):592-602. PubMed ID: 33369669
[TBL] [Abstract] [Full Text] [Related]
3. Mutation of the PTCH1 gene predicts recurrence of breast cancer.
Wang CY; Chang YC; Kuo YL; Lee KT; Chen PS; Cheung CHA; Chang CP; Phan NN; Shen MR; Hsu HP
Sci Rep; 2019 Nov; 9(1):16359. PubMed ID: 31704974
[TBL] [Abstract] [Full Text] [Related]
4. The effect of adipocyte-macrophage crosstalk in obesity-related breast cancer.
Engin AB; Engin A; Gonul II
J Mol Endocrinol; 2019 Apr; 62(3):R201-R222. PubMed ID: 30620711
[TBL] [Abstract] [Full Text] [Related]
5. Lung Transplantation for Lymphangioleiomyomatosis in Japan.
Ando K; Okada Y; Akiba M; Kondo T; Kawamura T; Okumura M; Chen F; Date H; Shiraishi T; Iwasaki A; Yamasaki N; Nagayasu T; Chida M; Inoue Y; Hirai T; Seyama K; Mishima M;
PLoS One; 2016; 11(1):e0146749. PubMed ID: 26771878
[TBL] [Abstract] [Full Text] [Related]
6. Death-associated protein kinase 1 promotes growth of p53-mutant cancers.
Zhao J; Zhao D; Poage GM; Mazumdar A; Zhang Y; Hill JL; Hartman ZC; Savage MI; Mills GB; Brown PH
J Clin Invest; 2015 Jul; 125(7):2707-20. PubMed ID: 26075823
[TBL] [Abstract] [Full Text] [Related]
7. Treatment outcome of patients with liver-only metastases from breast cancer after mastectomy: a retrospective analysis.
Duan XF; Dong NN; Zhang T; Li Q
J Cancer Res Clin Oncol; 2011 Sep; 137(9):1363-70. PubMed ID: 21789703
[TBL] [Abstract] [Full Text] [Related]
8. [Expression and significance of CD44(+)ESA(+)CD24(-/low), stem cell markers for breast cancer, in non-small-cell lung carcinoma].
Lu ZQ; Li HG; Zhang HZ; Fan MJ; Shen XM; He XX
Ai Zheng; 2008 Jun; 27(6):575-9. PubMed ID: 18570728
[TBL] [Abstract] [Full Text] [Related]
9. Maintenance of polarity and a dual cell population in adenoid cystic carcinoma of the breast: an immunohistochemical study.
Kasami M; Olson SJ; Simpson JF; Page DL
Histopathology; 1998 Mar; 32(3):232-8. PubMed ID: 9568508
[TBL] [Abstract] [Full Text] [Related]
